Status:

RECRUITING

A Study to Evaluate Non-significant Risk Operation Magnetic Resonance Imaging for MRI Guided Ablation

Lead Sponsor:

Mayo Clinic

Conditions:

Healthy

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The result of these studies will be used to improve patient care through assessment of new technology to determine whether it is beneficial (i.e. improving data acquisition speed or image quality) dur...

Detailed Description

This proposal includes evaluation of advanced MR imaging methods in the iMRI environment and will operate within the NSR guidelines for data acquisition established by the FDA/CDRH. The significant te...

Eligibility Criteria

Inclusion

  • Male or female.
  • Age ≥ 18 years.
  • Healthy volunteers or patients already scheduled for a MR-guided procedure.

Exclusion

  • Individuals 18 years of age.
  • Pregnant women.

Key Trial Info

Start Date :

August 30 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2027

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04880226

Start Date

August 30 2021

End Date

December 1 2027

Last Update

January 7 2026

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Mayo Clinic in Rochester

Rochester, Minnesota, United States, 55905

A Study to Evaluate Non-significant Risk Operation Magnetic Resonance Imaging for MRI Guided Ablation | DecenTrialz